These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 21606096

  • 1. Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study.
    Stephenson A, Seitz D, Bell CM, Gruneir A, Gershon AS, Austin PC, Fu L, Anderson GM, Rochon PA, Gill SS.
    Arch Intern Med; 2011 May 23; 171(10):914-20. PubMed ID: 21606096
    [Abstract] [Full Text] [Related]

  • 2. Inhaled anticholinergic drugs and risk of acute urinary retention.
    Afonso AS, Verhamme KM, Stricker BH, Sturkenboom MC, Brusselle GG.
    BJU Int; 2011 Apr 23; 107(8):1265-72. PubMed ID: 20880196
    [Abstract] [Full Text] [Related]

  • 3. Inhaled anticholinergics for chronic obstructive pulmonary disease: comment on "Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease".
    Singh S, Furberg CD.
    Arch Intern Med; 2011 May 23; 171(10):920-2. PubMed ID: 21606097
    [No Abstract] [Full Text] [Related]

  • 4. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
    Gershon A, Croxford R, Calzavara A, To T, Stanbrook MB, Upshur R, Stukel TA.
    JAMA Intern Med; 2013 Jul 08; 173(13):1175-85. PubMed ID: 23689820
    [Abstract] [Full Text] [Related]

  • 5. Nonsteroidal anti-inflammatory drugs and increased risk of acute urinary retention.
    Verhamme KM, Dieleman JP, Van Wijk MA, van der Lei J, Bosch JL, Stricker BH, Sturkenboom MC.
    Arch Intern Med; 2005 Jul 11; 165(13):1547-51. PubMed ID: 16009872
    [Abstract] [Full Text] [Related]

  • 6. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS, Wang L, To T, Luo J, Upshur RE.
    COPD; 2008 Aug 11; 5(4):229-34. PubMed ID: 18671148
    [Abstract] [Full Text] [Related]

  • 7. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.
    Arch Intern Med; 2009 Aug 10; 169(15):1403-10. PubMed ID: 19667304
    [Abstract] [Full Text] [Related]

  • 8. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr 10; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety.
    Tashkin DP.
    Curr Opin Pulm Med; 2010 Mar 10; 16(2):97-105. PubMed ID: 20019615
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
    Lee TA, Schumock GT, Bartle B, Pickard AS.
    Pharmacotherapy; 2009 Sep 10; 29(9):1039-53. PubMed ID: 19698009
    [Abstract] [Full Text] [Related]

  • 13. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS, Koerselman J, Erkens JA, Lammers JW, Herings RM.
    Respir Med; 2007 Jul 10; 101(7):1398-405. PubMed ID: 17368011
    [Abstract] [Full Text] [Related]

  • 14. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L.
    Am J Geriatr Pharmacother; 2008 Aug 10; 6(3):138-46. PubMed ID: 18775388
    [Abstract] [Full Text] [Related]

  • 15. The cardiovascular risk of tiotropium: is it real?
    Cazzola M, Calzetta L, Matera MG.
    Expert Opin Drug Saf; 2010 Sep 10; 9(5):783-92. PubMed ID: 20565229
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.